TURB:NASDAQTurbo Energy, S.A. Analysis
Data as of 2026-05-06 - not real-time
$1.47
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Turbo Energy’s stock is trading at $1.47, well below its 20‑day SMA of $1.89 and 50‑day SMA of $2.30, signaling a bearish price trend. The RSI sits at 38, edging toward oversold territory, while the MACD histogram remains negative, confirming downward momentum. Volume has been decreasing, and the 30‑day volatility is an extreme 199%, indicating a highly erratic price environment. Beta is strongly negative (≈ ‑4), suggesting the stock moves opposite to the market and amplifies its risk profile. On the fundamentals side, the company reports a massive revenue surge of 130‑140% for 2025, yet margins are deeply negative (operating margin ‑21%, profit margin ‑19%) and cash flow is consistently out of the red. Debt overwhelms equity with a debt‑to‑equity ratio above 600, and the price‑to‑book ratio exceeds 10, pointing to an overvalued valuation. Recent news highlights a new USPTO patent and a strategic partnership for AI‑driven storage, which could bolster future growth but does not yet translate into profitability.
Given the confluence of bearish technical signals, extreme volatility, and a fragile balance sheet, the upside appears limited despite the headline‑grabbing revenue growth. The stock’s liquidity is thin, market cap is only $17.7 M, and the current price sits near the identified support of $1.45, leaving little cushion for further downside. Investors should weigh the speculative upside of the patent and partnership against the high financial and market risks before committing capital.
Given the confluence of bearish technical signals, extreme volatility, and a fragile balance sheet, the upside appears limited despite the headline‑grabbing revenue growth. The stock’s liquidity is thin, market cap is only $17.7 M, and the current price sits near the identified support of $1.45, leaving little cushion for further downside. Investors should weigh the speculative upside of the patent and partnership against the high financial and market risks before committing capital.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- price below all major moving averages
- bearish MACD and RSI indicating continued downside
- decreasing volume and extreme volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- preliminary 2025 revenue growth of 130‑140% suggests upside potential
- persistent negative margins and cash flow constrain earnings
- high debt‑to‑equity and overvalued price‑to‑book ratio limit upside
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- ongoing negative earnings and free cash flow
- valuation appears stretched with P/B around 11
- structural sector and regulatory uncertainties
Key Metrics & Analysis
Financial Health
Revenue Growth11.50%
Profit Margin-18.78%
ROE-100.76%
ROA-13.93%
Debt/Equity619.90
P/B Ratio10.9
Op. Cash Flow$-2685216
Free Cash Flow$-2549818
Industry P/E37.2
Technical Analysis
TrendBearish
RSI38.0
Support$1.45
Resistance$2.70
MA 20$1.89
MA 50$2.30
MA 200$2.36
MACDBearish
VolumeDecreasing
Fear & Greed Index90.38
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta-2.78
Volatility198.77%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.